Association between serum soluble corin and hyperglycaemia: a cross-sectional study among Chinese adults
Yan Liu1, Hao Peng1, Qiu Zhang2
1Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, China Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, School of Public Health, Soochow University, Suzhou, China.
Objectives:
Decreased natriuretic peptides are risk factors for diabetes. As a physiological activator of natriuretic peptides, corin may play a role in glucose metabolism. Here, we aimed to test the hypothesis in a general population of China.
Design:
Cross-sectional study.
Setting:
A population study in Suzhou, China.
Participants:
A total of 2498 participants aged above 30 years were included in the study.
Outcome Measures:
The association between serum soluble corin and hyperglycaemia was examined in men and women, using non-conditional logistic regression models, respectively.
Results:
Serum soluble corin, in men and women, was significantly higher in participants with hyperglycaemia than in those without (all p<0.001). OR of hyperglycaemia positively and significantly increased with serum soluble corin quartiles, in men (p for trend <0.001) and in women (p for trend=0.050), even after multivariate adjustment. Participants with a serum soluble corin, in men (OR=1.66, 95% CI 1.24 to 2.23) and women (OR=1.27, 95% CI 1.00 to 1.61), over the median level, were more likely to have hyperglycaemia compared with the remaining participants, after controlling for confounding factors.
Conclusions:
Hyperglycaemia was significantly and positively associated with increased serum soluble corin in men and women. Our findings suggest that serum soluble corin may be a risk factor or a biomarker of hyperglycaemia.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Hypoglycemia and Glucagon
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Diabetes Mellitus: Type 2 and Gestational
Oral Hypoglycemic Agents: Biguanides and Glitazones
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
